In:
JAMA Oncology, American Medical Association (AMA), Vol. 8, No. 12 ( 2022-12-01), p. 1733-
Abstract:
This Viewpoint discusses therapeutic drug monitoring as a necessary treatment paradigm and the need for regulatory agencies to provide the conditions to make it happen.
Type of Medium:
Online Resource
ISSN:
2374-2437
DOI:
10.1001/jamaoncol.2022.4452
Language:
English
Publisher:
American Medical Association (AMA)
Publication Date:
2022
Permalink